Literature DB >> 12010209

Central retinal vein occlusion in pseudoexfoliation of the lens capsule.

William E Gillies1, Anne M V Brooks.   

Abstract

In surveying an extensive group of patients with unilateral pseudoexfoliation of the lens capsule certain interesting points emerged, particularly on the incidence of central retinal vein occlusion in this condition,and perhaps in glaucoma also. A total of 284 patients with unilateral pseudo-exfoliation of the lens capsule were examined clinically after an ophthalmic and general history were taken. Mean intraocular pressure (IOP) was 30.9 mmHg in the affected eye and 18.1 mmHg in the unaffected eye. Central retinal vein occlusion occurred in 10 affected eyes but no unaffected eyes and always in affected eyes with a rise in IOP. Average IOP in the affected eye with central retinal vein occlusion was 37.5 mmHg (range 26-54 mmHg);in the unaffected fellow eye it was 18.0 mmHg (range 11-28 mmHg). Although the process involved in producing pseudo-exfoliation of the lens capsule may contribute to the precipitation of central retinal vein occlusion, these findings suggest the rise in IOP is the more important cause. This may also be so in other forms of glaucoma.

Entities:  

Mesh:

Year:  2002        PMID: 12010209     DOI: 10.1046/j.1442-9071.2002.00513.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

1.  Relation between time spent outdoors and exfoliation glaucoma or exfoliation glaucoma suspect.

Authors:  Jae H Kang; Janey L Wiggs; Louis R Pasquale
Journal:  Am J Ophthalmol       Date:  2014-05-20       Impact factor: 5.258

2.  Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts.

Authors:  Jae Hee Kang; Stephanie Loomis; Janey L Wiggs; Joshua D Stein; Louis R Pasquale
Journal:  Ophthalmology       Date:  2011-10-07       Impact factor: 12.079

Review 3.  [Secondary open-angle glaucoma: pseudoexfoliative glaucoma, pigmentary glaucoma and neovascular glaucoma].

Authors:  Roman Greslechner; Horst Helbig; Detlev Spiegel
Journal:  Ophthalmologe       Date:  2022-04-01       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.